171 related articles for article (PubMed ID: 30967480)
1. Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach.
Friemel J; Frick L; Unger K; Egger M; Parrotta R; Böge YT; Adili A; Karin M; Luedde T; Heikenwalder M; Weber A
Mol Cancer Res; 2019 Jul; 17(7):1493-1502. PubMed ID: 30967480
[TBL] [Abstract][Full Text] [Related]
2. Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer.
Yim SY; Shim JJ; Shin JH; Jeong YS; Kang SH; Kim SB; Eun YG; Lee DJ; Conner EA; Factor VM; Moore DD; Johnson RL; Thorgeirsson SS; Lee JS
Mol Cancer Res; 2018 Nov; 16(11):1713-1723. PubMed ID: 30082483
[TBL] [Abstract][Full Text] [Related]
3. Integrative genomic analysis of mouse and human hepatocellular carcinoma.
Dow M; Pyke RM; Tsui BY; Alexandrov LB; Nakagawa H; Taniguchi K; Seki E; Harismendy O; Shalapour S; Karin M; Carter H; Font-Burgada J
Proc Natl Acad Sci U S A; 2018 Oct; 115(42):E9879-E9888. PubMed ID: 30287485
[TBL] [Abstract][Full Text] [Related]
4. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
[TBL] [Abstract][Full Text] [Related]
5. The role of bone marrow-derived cells in the origin of liver cancer revealed by single-cell sequencing.
Chen L; Yi X; Guo P; Guo H; Chen Z; Hou C; Qi L; Wang Y; Li C; Liu P; Liu Y; Xu Y; Zhang N
Cancer Biol Med; 2020 Feb; 17(1):142-153. PubMed ID: 32296582
[No Abstract] [Full Text] [Related]
6. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
7. Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression.
Mello T; Materozzi M; Zanieri F; Simeone I; Ceni E; Bereshchenko O; Polvani S; Tarocchi M; Marroncini G; Nerlov C; Guasti D; Bani D; Pinzani M; Galli A
Int J Cancer; 2020 Jun; 146(12):3410-3422. PubMed ID: 31721195
[TBL] [Abstract][Full Text] [Related]
8. Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease.
Chappell G; Silva GO; Uehara T; Pogribny IP; Rusyn I
Cancer Med; 2016 Mar; 5(3):574-85. PubMed ID: 26778414
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of hepatocarcinogenesis using mouse models.
Teoh WW; Xie M; Vijayaraghavan A; Yaligar J; Tong WM; Goh LK; Sabapathy K
Dis Model Mech; 2015 Jul; 8(7):743-53. PubMed ID: 26035378
[TBL] [Abstract][Full Text] [Related]
10. Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease.
Ambade A; Satishchandran A; Gyongyosi B; Lowe P; Szabo G
World J Gastroenterol; 2016 Apr; 22(16):4091-108. PubMed ID: 27122661
[TBL] [Abstract][Full Text] [Related]
11. Recurrent and nonrandom DNA copy number and chromosome alterations in Myc transgenic mouse model for hepatocellular carcinogenesis: implications for human disease.
Zimonjic DB; Ullmannova-Benson V; Factor VM; Thorgeirsson SS; Popescu NC
Cancer Genet Cytogenet; 2009 May; 191(1):17-26. PubMed ID: 19389504
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma.
Tan S; Zhao J; Sun Z; Cao S; Niu K; Zhong Y; Wang H; Shi L; Pan H; Hu J; Qian L; Liu N; Yuan J
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14231-14242. PubMed ID: 32513687
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of DEN-induced liver tumourigenesis in hepatocyte-specific Lass2-knockout mice coincident with upregulation of the TGF-β1-Smad4-PAI-1 axis.
Chen L; Lu X; Zeng T; Chen Y; Chen Q; Wu W; Yan X; Cai H; Zhang Z; Shao Q; Qin W
Oncol Rep; 2014 Feb; 31(2):885-93. PubMed ID: 24337404
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Hepatocyte Chemerin-156 Lowers Tumor Burden in a Murine Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma.
Haberl EM; Pohl R; Rein-Fischboeck L; Feder S; Sinal CJ; Bruckmann A; Hoering M; Krautbauer S; Liebisch G; Buechler C
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905933
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
[TBL] [Abstract][Full Text] [Related]
16. Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib.
Groß C; Steiger K; Sayyed S; Heid I; Feuchtinger A; Walch A; Heß J; Unger K; Zitzelsberger H; Settles M; Schlitter AM; Dworniczak J; Altomonte J; Ebert O; Schwaiger M; Rummeny E; Steingötter A; Esposito I; Braren R
Clin Cancer Res; 2015 Oct; 21(19):4440-50. PubMed ID: 25995341
[TBL] [Abstract][Full Text] [Related]
17. Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma.
Rappa F; Greco A; Podrini C; Cappello F; Foti M; Bourgoin L; Peyrou M; Marino A; Scibetta N; Williams R; Mazzoccoli G; Federici M; Pazienza V; Vinciguerra M
PLoS One; 2013; 8(1):e54458. PubMed ID: 23372727
[TBL] [Abstract][Full Text] [Related]
18. Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.
Lu M; Wu J; He F; Wang XL; Li C; Chen ZN; Bian H
J Mol Histol; 2015 Feb; 46(1):79-91. PubMed ID: 25447507
[TBL] [Abstract][Full Text] [Related]
19. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T
Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407
[TBL] [Abstract][Full Text] [Related]
20. Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma.
Mittenbühler MJ; Sprenger HG; Gruber S; Wunderlich CM; Kern L; Brüning JC; Wunderlich FT
Mol Metab; 2018 Nov; 17():122-133. PubMed ID: 30224299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]